Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The CD94 NK cell receptor is assembled as a disulfide-linked dimer and appears to be encoded by a single-copy gene of the C-type lectin superfamily. In reverse Ab-dependent cellular cytotoxicity assays, CD94-specific mAbs may either trigger or inhibit cytotoxicity in distinct subsets of NK clones, termed groups A and B, respectively. The molecular basis for this functional ambivalence of CD94 has been addressed. CD94 molecules immunoprecipitated with the HP-3B1 mAb from the two different subsets of NK clones were comparatively analyzed by SDS-PAGE. Under reducing conditions, the stimulating form of CD94 from group A clones displayed a significantly lower Mr (39 kDa) than the inhibitory form of group B clones (Mr = 43 kDa). Analyses of N-glycanase and V8 protease-digested samples indicated that the two CD94 forms are homologous. A CD94-specific mAb (Z199) that did not recognize cells transfected with a CD94 cDNA (LL288) was characterized. Z199 did not bind to group A clones, whereas its reactivity with group B NK cells was indistinguishable from that of other CD94-specific mAbs. Different from the HP-3B1 mAb, the Z199 mAb displayed only inhibitory effects in reverse Ab-dependent cellular cytotoxicity assays. Immunoprecipitation studies confirmed that Z199 selectively identified the 43-kDa CD94. Our study proves the existence of at least two biochemically and serologically distinct CD94 molecules, whose selective/predominant expression at the clonal level correlates with the pattern of response (i.e., inhibition vs activation) of NK cells to ligation by CD94-specific mAbs.

Type

Journal article

Journal

Journal of Immunology

Publication Date

15/12/1996

Volume

157

Pages

5367 - 5374